Biostatistics & Bioinformatics Shared Resource

BBSR Home | Services & Fees | Educational Resources | Publications | Schedule

Publications

2003 2004 2005 2006 2007 2008

2003

Baldassarre LA, Steiner NK, Jones P, Tang T, Slack R, Ng J, Hartzman RJ, Hurley CK. Limited diversity of HLA-DRB1*02 alleles and DRB1-DRB5 haplotype associations in four United States populations groups. Tissue Antigens 61:249-252, 2003.

Han Z, Slack R, Li W, Papadopoulos V. Expression of peripheral benzodiazepine receptor (PBR) in human tumors: relationship to breast, colorectal, and prostate tumor progression. J. Recept. Signal. Transduct. Res. 23(2-3):225-38, 2003.

Johnson MD, Kenney N, Stoica A, Hilakivi-Clarke L, Singh B, Chepko G, Clarke R, Sholler PF, Lirio AA, Foss C, Reiter R, Trock B, Paik S, Martin MB. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat Med 9(8):1081-1084, 2003.

Kerner JF, Yedidia M, Padgett D, Muth B, Washington KS, Tefft, M, Yabroff KR, Makariou E, Freeman H, Mandelblatt JS. Realizing the promise of breast cancer screening: Clinical follow-up after abnormal screening among Black women. Prev. Med. 37:92-101, 2003.

Liang W, Lawrence WF, Burnett CB, Hwang YT, Freedman M, Trock B, Mandelblatt JS, Lippman ME. Acceptability of diagnostic tests for breast cancer. Breast Cancer Research and Treatment 79(2):199-206, 2003.

Rizzuto G, Li L, Steiner N, Slack R, Tang T, Heine U, Lin Y, Ng J, Hartzman RJ, Hurley CK. Diversity within the DRB1*08 allele family In four populations from a United States hematopoietic stem cell donor database and characterization of five novel DRB1*08 alleles. Human Immunology, 64:607-613, 2003.

Stearns V, Singh B, Tsangaris T, Carwford J, Novielli A, Ellis MJ, Isaacs C, Pennanen M, Tibery C, Farhad A, Slack R, Hayes DF. A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neadjuvant Doxorubicin or Paclitaxel for patients with locally advanced breast cancer. Clinical Cancer Research 9:124-133, 2003.

Atlas E, Cardillo M, Mehmi I, Zahedkargaran H, Tang C, Lupu R. Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo. Mol Cancer Res 1(3):165-175, 2003.

Johnson M, Kenney N, Stoica A, Hilakivi-Clarke L, Singh B, Chepko G, Clarke R, Sholler PF, Lirio AA, Foss C, Reiter R, Trock B, Paik S, Martin MB. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat. Med., 2003.

Luo XY, Gong XQ, Tang CK. Suppression of EGFRvIII-mediated proliferation and tumorigenesis of breast cancer cells by ribozyme. Int. J. Cancer 104:716-721, 2003.

Sommer S, Jiang Z, Feng J, Buzin CH, Zheng J, Longmate J, Jung M, Moulds J, Dritschilo A. ATM missense mutations are frequent in patients with breast cancer. Cancer Genet. Cytogenet. 145:115-120, 2003.

Tsai MS, Shamon-Taylor LA, Mehmi I, Tang CK, Lupu R. Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer. Oncogene 22(5):761-768, 2003.

Zheng YL, Loffredo CA, Yu Z, Jones RT, Krasna MJ, Alberg AJ, Yung R, Perlmutter D, Enewold L, Harris CH, Shields PG. Bleomysin-induced chromosome breaks as a risk marker for lung cancer: a cade-control study with population and hospital controls. Carcinogenesis 24:269-274, 2003.

Liu A and Hall WJ. A simple low-bias estimate following a sequential test with linear boundaries. In: Crossing Boundaries: Statistical Essays in Honor of Jack Hall, IMS Monograph Series, Kolassa J, Oakes D (editors), pp. 47-58, 2003.

Mazumdar M, Liu A. Group sequential design for comparative diagnostic accuracy studies. Statistics in Medicine 22:727-739, 2003.

Oakes D, Wang A, A copula model generated by Dabrowska's association measure. Biometrika, 90:478-481, 2003.